Day One Biopharmaceuticals
CA - BrisbanePharmaceutical
Focus: Day One Biopharmaceuticals is an oncology-focused biopharmaceutical company developing targeted cancer treatments, with a marketed product (OJEMDA/tovorafenib) and an active pipeline spanning multiple tumor types.
Profile data last refreshed 11h ago · AI intelligence enriched 3w ago
Open Jobs
0
About Day One Biopharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Day One Biopharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Growing
Growth8.8yr
FDA-approved Type II RAF kinase inhibitor in growth phase with 9+ year exclusivity runway; supports commercial infrastructure and validates platform.
Help build intelligence for Day One Biopharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.